Dainippon and Kyoto University's Center for iPS Cell Research and Application (CiRA) partnered to develop a treatment for an undisclosed rare disease

Kyoto University

Japan / Academic

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Dainippon Sumitomo Pharma Co. Ltd.

Japan / Mid-Cap Biopharma ($1-$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced